STATEMENT OF GLP QUALITY ASSURANCE ACTIVITIES FOR NONCLINICAL LABORATORY STUDIES Reference REG-003,...

7

Transcript of STATEMENT OF GLP QUALITY ASSURANCE ACTIVITIES FOR NONCLINICAL LABORATORY STUDIES Reference REG-003,...

Page 1: STATEMENT OF GLP QUALITY ASSURANCE ACTIVITIES FOR NONCLINICAL LABORATORY STUDIES Reference REG-003, REG-006, FDA 21 CFR 58 Study Information Study Number. Test Number(s). study Title.
Page 2: STATEMENT OF GLP QUALITY ASSURANCE ACTIVITIES FOR NONCLINICAL LABORATORY STUDIES Reference REG-003, REG-006, FDA 21 CFR 58 Study Information Study Number. Test Number(s). study Title.
Page 3: STATEMENT OF GLP QUALITY ASSURANCE ACTIVITIES FOR NONCLINICAL LABORATORY STUDIES Reference REG-003, REG-006, FDA 21 CFR 58 Study Information Study Number. Test Number(s). study Title.
Page 4: STATEMENT OF GLP QUALITY ASSURANCE ACTIVITIES FOR NONCLINICAL LABORATORY STUDIES Reference REG-003, REG-006, FDA 21 CFR 58 Study Information Study Number. Test Number(s). study Title.
Page 5: STATEMENT OF GLP QUALITY ASSURANCE ACTIVITIES FOR NONCLINICAL LABORATORY STUDIES Reference REG-003, REG-006, FDA 21 CFR 58 Study Information Study Number. Test Number(s). study Title.
Page 6: STATEMENT OF GLP QUALITY ASSURANCE ACTIVITIES FOR NONCLINICAL LABORATORY STUDIES Reference REG-003, REG-006, FDA 21 CFR 58 Study Information Study Number. Test Number(s). study Title.
Page 7: STATEMENT OF GLP QUALITY ASSURANCE ACTIVITIES FOR NONCLINICAL LABORATORY STUDIES Reference REG-003, REG-006, FDA 21 CFR 58 Study Information Study Number. Test Number(s). study Title.

2.4 Nonclinical Overview

2.4 Nonclinical Overview

Nonclinical Drug Development - pcp.nihtraining.com · Nonclinical Drug Development Chris H. Takimoto, MD, PhD, ... – Targeted therapies/Biomarkers ... –Selective –Predictable

Nonclinical Drug Development - pcp.nihtraining.com · Nonclinical Drug Development Chris H. Takimoto, MD, PhD, ... – Targeted therapies/Biomarkers ... –Selective –Predictable

Covance Biosimilars: Nonclinical & Clinical Development Challenges & Considerations

Covance Biosimilars: Nonclinical & Clinical Development Challenges & Considerations

Nonclinical approaches to study shedding of gene therapy ...Nonclinical approaches to study shedding of gene therapy vectors E.S. van Amersfoort, PhD. Shedding as preclinical issue

Nonclinical approaches to study shedding of gene therapy ...Nonclinical approaches to study shedding of gene therapy vectors E.S. van Amersfoort, PhD. Shedding as preclinical issue

Nonclinical Safety Assessment of Biotherapeutics 11... · o ICH S9 [Nonclinical evaluation for anticancer pharmaceuticals] o ICH M3(R2) [Guidance on nonclinical safety studies for

Nonclinical Safety Assessment of Biotherapeutics 11... · o ICH S9 [Nonclinical evaluation for anticancer pharmaceuticals] o ICH M3(R2) [Guidance on nonclinical safety studies for

Discover our citoxlab nonclinical services

Discover our citoxlab nonclinical services

MODULE 2.4 NONCLINICAL OVERVIEW - 独立行政法人 ...€¦ · confidential m2.4. nonclinical overview 2012n153960_00 2 table of contents page 1. overview of the nonclinical testing

MODULE 2.4 NONCLINICAL OVERVIEW - 独立行政法人 ...€¦ · confidential m2.4. nonclinical overview 2012n153960_00 2 table of contents page 1. overview of the nonclinical testing

Nonclinical Statistics Conference Paris 2018 Lessons ...

Nonclinical Statistics Conference Paris 2018 Lessons ...

Nonclinical Overview Artemisinin-Derivatives

Nonclinical Overview Artemisinin-Derivatives

Current situation on nonclinical safety evaluation of ...

Current situation on nonclinical safety evaluation of ...

TRAINING COURSE ONCOLOGY NONCLINICAL DEVELOPMENT …

TRAINING COURSE ONCOLOGY NONCLINICAL DEVELOPMENT …

Nonclinical Safety Evaluation of Inhalation Drug Products · Nonclinical Safety Evaluation of Inhalation Drug Products February ... an increasingly popular route of drug ... The nonclinical

Nonclinical Safety Evaluation of Inhalation Drug Products · Nonclinical Safety Evaluation of Inhalation Drug Products February ... an increasingly popular route of drug ... The nonclinical

Nonclinical Studies to Support Clinical Trials · 2020-02-21 · 1. Preclinical Safety Assessments • Nonclinical study recommendationsto support FIH studies-Regulatory guidances:

Nonclinical Studies to Support Clinical Trials · 2020-02-21 · 1. Preclinical Safety Assessments • Nonclinical study recommendationsto support FIH studies-Regulatory guidances:

REG Small Airways Study Group Meeting

REG Small Airways Study Group Meeting

Nonclinical Study Plan/Protocol Template for Repeat-Dose …€¦ · Nonclinical Safety Studies for the Conduct of Human Clinical Trials for Pharmaceuticals and Marketing Authorization

Nonclinical Study Plan/Protocol Template for Repeat-Dose …€¦ · Nonclinical Safety Studies for the Conduct of Human Clinical Trials for Pharmaceuticals and Marketing Authorization

Regulatory Toxicology A Nonclinical Pharmacology and ... 2015_Day 4_Regulatory... · A Nonclinical Pharmacology and Toxicology Perspectiveand Toxicology Perspective ... – Cli i

Regulatory Toxicology A Nonclinical Pharmacology and ... 2015_Day 4_Regulatory... · A Nonclinical Pharmacology and Toxicology Perspectiveand Toxicology Perspective ... – Cli i

Nonclinical Working Group, SDRG Project – PP09 FINAL Poster .pdfTechnical Document (eCTD) in Module 5. (Module 4 for nonclinical studies.) For each study, the Data Guide should include,

Nonclinical Working Group, SDRG Project – PP09 FINAL Poster .pdfTechnical Document (eCTD) in Module 5. (Module 4 for nonclinical studies.) For each study, the Data Guide should include,

Nonclinical evaluation of oral antiviral agents...– Which population to study • Naives, relapsers, partial/null responders, genotype, IL28B polymorphism? – Sustained virological

Nonclinical evaluation of oral antiviral agents...– Which population to study • Naives, relapsers, partial/null responders, genotype, IL28B polymorphism? – Sustained virological

Nonclinical Evaluation Vaccines Nov 2003

Nonclinical Evaluation Vaccines Nov 2003

ICH guideline S12 on nonclinical biodistribution ...

ICH guideline S12 on nonclinical biodistribution ...